Congresswoman Maxine Waters (CA-43), the Chair of the House Financial Services Committee and a member of the Congressional Diabetes Caucus, introduced the Affordable Insulin for the COVID-19 Emergency Act today.
“The Affordable Insulin for the COVID-19 Emergency Act will ensure that seniors are able to afford a sufficient supply of insulin to manage their diabetes effectively without leaving the safety of their homes.”
The Affordable Insulin for the COVID-19 Emergency Act will require that seniors who are enrolled in Medicare Part D prescription drug plans be able to obtain insulin and associated medical supplies to manage their diabetes without copayments, coinsurance, deductibles, or other cost-sharing between now and the end of the COVID-19 emergency.
“The Affordable Insulin for the COVID-19 Emergency Act marks a key step in protecting Americans living with diabetes at this unusually difficult time for the diabetes community,” said Tracey Brown, CEO of the American Diabetes Association.
“COVID-19 is having a disproportionate impact on seniors, and seniors with diabetes face particularly high risks,” said Congresswoman Waters.
